Superficial pyoderma: topical chlorhexidine vs systemic amoxicillin-clavulanate — POSSIBLE

In dogs with superficial bacterial folliculitis (superficial pyoderma), is daily topical chlorhexidine non-inferior to systemic amoxicillin-clavulanate for lesion resolution?

Shelf #141 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: In the one randomised, blinded, antibiotic-controlled trial (51 dogs; indexed single-blind), a combined 4% chlorhexidine digluconate protocol — shampoo twice weekly plus solution once daily for 4 weeks — produced pyoderma and pruritus scores not significantly different from systemic amoxicillin-clavulanic acid 25 mg/kg twice daily at every point after day 1, and clinical signs resolved in all dogs, including the eight infected with meticillin-resistant Staphylococcus pseudintermedius (MRSP). But the trial tested for a difference, not for non-inferiority: no non-inferiority margin is reported, the groups were small and unbalanced (31 topical vs 20 systemic), and day-1 total scores already differed between groups (P = 0.03), so 'non-inferior' overstates what the design can show — 'no difference detected, with full resolution in both arms' is the supported wording. Supporting evidence is consistent: chlorhexidine shampoo as sole therapy significantly reduced lesion scores and bacterial counts in a randomised, partially blinded trial, and randomised MRSP-carriage data suggest topical antimicrobial therapy clears carriage only temporarily (55.6% vs 33.3% with hygiene alone, in very small numbers). Drafted Nov 10, 2026 (VetMed build, topic #141); all figures from abstracts fetched and verified at drafting.

Borio 2015: 4% chlorhexidine shampoo plus daily solution matched amoxicillin-clavulanate on pyoderma scores, with resolution in all dogs including 8 with MRSP

Randomized, blinded, antibiotic-controlled study (record's own title wording; publication type: Randomized Controlled Trial; MeSH index includes Single-Blind Method)

Who: Dogs: dogs with superficial pyoderma in a randomized controlled trial; Group T (n = 31) was treated topically with 4% chlorhexidine digluconate shampoo (twice weekly) and solution (once daily) for 4 weeks, and Group S (n = 20) was treated orally with amoxicillin-clavulanic acid (25 mg/kg) twice daily for 4 weeks. Bacterial culture and susceptibility testing were performed before treatment; lesion severity and intracellular bacteria were scored on four-point scales and pruritus by owners on a visual analog scale (0-10).

Result: Staphylococcus pseudintermedius was isolated from 48 dogs, including eight meticillin-resistant strains (MRSP). No significant differences in pyoderma and pruritus scores were observed between groups throughout the study except for day 1, when group S had a significantly higher total score than group T (P = 0.03). Treatment with chlorhexidine products resulted in resolution of clinical signs in all dogs including those infected with MRSP. The authors conclude topical therapy with chlorhexidine digluconate products may be as effective as systemic therapy with amoxicillin-clavulanic acid, supporting current recommendations to use topical antiseptics alone for the management of superficial pyoderma.

Watch out: Anchor verified, with two refinements of the draft's framing. First, the topical arm is a combined protocol — shampoo twice weekly AND solution once daily — not a single daily product. Second, this is a difference-testing trial, not a non-inferiority trial: no non-inferiority margin is reported, so the record supports 'no significant difference detected', not proven non-inferiority. Groups were unbalanced (31 vs 20) and total scores already differed at day 1 (P = 0.03, higher in the systemic group). The MRSP finding — resolution in all MRSP dogs — rests on eight dogs. The record's MeSH indexes the organism under 'Methicillin-Resistant Staphylococcus aureus' although the abstract reports S. pseudintermedius isolates; the MeSH is copied as the record prints it.

Borio S, Colombo S, La Rosa G, De Lucia M, Damborg P, Guardabassi L. Effectiveness of a combined (4% chlorhexidine digluconate shampoo and solution) protocol in MRS and non-MRS canine superficial pyoderma: a randomized, blinded, antibiotic-controlled study. Vet Dermatol. 2015;26(5):339-44, e72. PMID: 26140535. Registry ID: none in the record. MeSH: Administration, Topical · Amoxicillin-Potassium Clavulanate Combination/administration & dosage,therapeutic use · Animals · Chlorhexidine/administration & dosage,analogs & derivatives,therapeutic use · Dog Diseases/drug therapy,microbiology · Dogs · Drug Therapy, Combination/veterinary · Female · Male · Methicillin-Resistant Staphylococcus aureus/drug effects · Microbial Sensitivity Tests · Pyoderma/drug therapy,microbiology,veterinary · Single-Blind Method · Staphylococcal Skin Infections/drug therapy,veterinary

Loeffler 2011: chlorhexidine shampoo alone significantly reduced lesion scores and bacterial counts over 3 weeks in superficial pyoderma

Randomised, partially blinded comparative study (record's own wording)

Who: Dogs: 22 dogs with superficial pyoderma in a randomised, partially blinded study, washed two to three times weekly with a 10-minute contact time over 21 days with either a 3 per cent chlorhexidine gluconate shampoo or a 2.5 per cent benzoyl peroxide shampoo, used as sole antibacterial treatment; clinical scores and bacterial counts were assessed on days 1, 8 and 22.

Result: Twenty dogs completed the study; 15 (68.2 per cent) showed an overall clinical improvement and the clinical signs resolved in three chlorhexidine-treated dogs. In the chlorhexidine-treated group, scores for papules/pustules (P<0.001), investigator-assessed pruritus (P=0.003), total bacterial counts (P=0.003) and counts for coagulase-positive staphylococci (P=0.003) were reduced after three weeks. Scores and bacterial counts did not vary significantly in the benzoyl peroxide-treated group.

Watch out: The comparator here is another topical antiseptic (benzoyl peroxide), not a systemic antibiotic, and complete resolution within 3 weeks occurred in only three chlorhexidine-treated dogs — this card supports 'chlorhexidine shampoo alone is active treatment', not 'topical therapy resolves most cases quickly'. Twenty-two dogs, two of which did not complete the study.

Loeffler A, Cobb MA, Bond R. Comparison of a chlorhexidine and a benzoyl peroxide shampoo as sole treatment in canine superficial pyoderma. Vet Rec. 2011;169(10):249. PMID: 21831997. Registry ID: none in the record. MeSH: Administration, Topical · Animals · Anti-Infective Agents, Local/administration & dosage,therapeutic use · Benzoyl Peroxide/administration & dosage,therapeutic use · Chlorhexidine/administration & dosage,therapeutic use · Dermatologic Agents/administration & dosage,therapeutic use · Dog Diseases/drug therapy · Dogs · Dose-Response Relationship, Drug · Female · Male · Pyoderma/drug therapy,veterinary · Random Allocation · Staphylococcal Skin Infections/drug therapy,veterinary · Treatment Outcome

Frosini 2022: topical antimicrobial therapy cleared MRSP carriage in 5/9 dogs vs 2/6 with hygiene alone — and carriage often recurred

Randomised-allocation clinical study (record's own wording: carrier dogs 'allocated randomly'; blinding not stated)

Who: Dogs: 46 index dogs recovered from MRSP infection and 24 contact dogs, swabbed for meticillin-resistant Staphylococcus pseudintermedius carriage; carrier dogs were allocated randomly to topical fusidic acid and chlorhexidine/miconazole treatment combined with a household hygiene protocol (H&T) or hygiene alone (H) over three weeks, and carriage-negative dogs were monitored monthly.

Result: At inclusion, MRSP carriage was confirmed in 31/46 (67.4%) index dogs and 16/24 (66.7%) contact dogs, and contamination was found in 18/40 (45%) environments. In dogs completing all cycles, interventions cleared carriage in 5/9 (55.6%) dogs in group H&T and 2/6 (33.3%) in group H. Monthly monitoring of initially negative dogs showed intermittent carriage in 9/14 dogs. The authors conclude MRSP carriage was common after recovery from infection, topical antimicrobial therapy temporarily eliminated carriage but recurrence was frequent, and management must include prevention of recurrent infections and hygiene.

Watch out: This is the MRSP card, and it is deliberately about carriage after recovery from infection, not resolution of active pyoderma lesions — the topical regimen also combined fusidic acid with chlorhexidine/miconazole, so no chlorhexidine-specific effect can be separated. Numbers completing all cycles are very small (9 and 6 dogs). It tempers the anchor's MRSP optimism: topical therapy can clear MRSP from the skin surface temporarily, but carriage recurs, which is why recurrent MRSP pyoderma is not settled by the Borio result alone.

Frosini SM, Bond R, King R, Feudi C, Schwarz S, Loeffler A. Effect of topical antimicrobial therapy and household cleaning on meticillin-resistant Staphylococcus pseudintermedius carriage in dogs. Vet Rec. 2022;190(8):e937. PMID: 34582577. Registry ID: none in the record. MeSH: Animals · Anti-Bacterial Agents/pharmacology,therapeutic use · Anti-Infective Agents/pharmacology · Dog Diseases/drug therapy,prevention & control · Dogs · Methicillin · Methicillin Resistance · Methicillin-Resistant Staphylococcus aureus · Microbial Sensitivity Tests/veterinary · Staphylococcal Infections/drug therapy,veterinary · Staphylococcus

Synthesis: topical chlorhexidine performed as well as systemic amoxicillin-clavulanate in the one head-to-head trial — as 'no difference detected', not proven non-inferiority

Synthesis

Who: Synthesis of the cards above: Borio 2015 (51 dogs with superficial pyoderma, randomised blinded antibiotic-controlled trial), Loeffler 2011 (22 dogs, randomised partially blinded shampoo comparison) and Frosini 2022 (46 index dogs recovered from MRSP infection, randomised carriage study).

Result: For lesion resolution in superficial bacterial folliculitis, the head-to-head randomised trial found no significant difference between a 4-week combined chlorhexidine protocol and systemic amoxicillin-clavulanate, with clinical signs resolving in all treated dogs including eight MRSP cases. Chlorhexidine shampoo alone also significantly reduced lesion scores and staphylococcal counts versus baseline-era comparison in a second randomised trial. The honest summary is that topical chlorhexidine is a credible sole therapy for superficial pyoderma on current evidence — the gap is precision: small samples, no non-inferiority margin, and MRSP carriage data showing clearance is often temporary.

Watch out: Deep pyoderma, pyoderma secondary to uncontrolled underlying disease, and cases failing topical therapy are outside these records. Owner compliance with twice-weekly shampooing plus daily solution over 4 weeks is part of the intervention as tested; less intensive home regimens were not the anchor protocol.

Synthesis of Borio S et al. PMID: 26140535; Loeffler A et al. PMID: 21831997; Frosini SM et al. PMID: 34582577. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.